Sympathetic overactivity in hypertension. A moving target.
about
Targeting cardiac mast cells: pharmacological modulation of the local renin-angiotensin systemTestosterone increased blood pressure and decreased renal tyrosine hydroxylase activity in SHR/y and Wistar-Kyoto ratsThe expression level of ecto-NTP diphosphohydrolase1/CD39 modulates exocytotic and ischemic release of neurotransmitters in a cellular model of sympathetic neuronsEffects of Hatha yoga on blood pressure, salivary α-amylase, and cortisol function among normotensive and prehypertensive youth.Resting Heart Rate and Auditory Evoked PotentialRegional responsiveness of renal perfusion to activation of the renal nerves.Pheochromocytoma: a paradigm for catecholamine-mediated hypertension.Autonomic nervous system and microvascular alterations in normotensives with a family history of hypertension.Reciprocal functional interactions between the brainstem and the lower spinal cordAssociation of blood pressure variability with orthostatic intolerance symptoms.Nonlinear methods to assess changes in heart rate variability in type 2 diabetic patientsImpact of prehypertension on left ventricular structure, function and geometryCardiovascular pathways: socioeconomic status and stress effects on hypertension and cardiovascular function.Effects of metformin on endothelial health and erectile dysfunction.A randomized controlled trial on effects of the Transcendental Meditation program on blood pressure, psychological distress, and coping in young adultsUnderstanding the metabolic syndrome: a modeling perspectiveVav3 is involved in GABAergic axon guidance events important for the proper function of brainstem neurons controlling cardiovascular, respiratory, and renal parameters.The hypothalamus and hypertension.Use of beta-blockers in obesity hypertension: potential role of weight gain.Relationships of adrenoceptor polymorphisms with obesityPrevalence of sympathetic overactivity in hypertensive patients - a pan India, non-interventional, cross sectional study.The activity of single vasoconstrictor nerve units in hypertension.Alpha-adrenergic receptor gene polymorphisms and cardiovascular reactivity to stress in Black adolescents and young adults.Clinical and Pre-clinical Applications of the Transcendental Meditation Program in the Prevention and Treatment of Essential Hypertension and Cardiovascular Disease in Youth and Adults.Aerobic exercise and strength training effects on cardiovascular sympathetic function in healthy adults: a randomized controlled trial.Impact of transcendental meditation on left ventricular mass in african american adolescentsHypothesis: set-points and long-term control of arterial pressure. A theoretical argument for a long-term arterial pressure control system in the brain rather than the kidney.Prevention and Treatment of Cardiovascular Disease in Adolescents and Adults through the Transcendental Meditation(®) Program: A Research Review Update.Hypertension, kidney, and transgenics: a fresh perspective.Association of ambulatory heart rate and atherosclerosis risk factors with blood pressure in young non-hypertensive adultsReciprocal functional interactions between the respiration/circulation center, the upper spinal cord, and the trigeminal system.G protein-coupled receptor kinase 2 expression and activity are associated with blood pressure in black Americans.Hypertension in the teenager.Effects of exercise training on cardiovascular adrenergic system.Effects of acute and chronic exercise in patients with essential hypertension: benefits and risks.Prehypertension: Defining the Transitional Phenotype.Circadian systemic haemodynamics in borderline and mild hypertension.Stress and Addiction: When a Robust Stress Response Indicates Resiliency.Role of alpha adrenoceptors and nitric oxide on cardiovascular responses in acute and chronic hypertension.Increased pulse pressure is associated with reduced baroreflex sensitivity.
P2860
Q27026966-9AC2916D-AA2E-4F2F-ACA0-FFEB859503D3Q28567249-E69715E2-2BF2-4BC6-892A-A7D29182DAD0Q28575419-318317B9-2EB4-4059-9820-CB4158C31B7AQ30360116-9512861B-6AC9-40C9-A983-D0851AA9B65CQ30400518-4009AB40-9425-42D8-B7F8-C053CB297508Q30862442-CB684DBB-07BE-4A31-AE69-EE80DB89C64FQ30978416-192A31B9-98C4-4760-A9C7-877671DF4C3CQ31072952-B0A7AACC-7D44-4262-8354-D8CDAE19DE73Q33688634-61D301C8-2A4C-44AE-BA90-3D56B963AD0FQ33773182-97F0612D-194B-4A95-865B-009F9607F159Q33773337-89A18AF5-3772-45C0-A433-F1887AF36203Q33783561-5FCC88E9-75CF-42CB-85F4-DB3F162975F7Q33842176-FE176946-FD53-4AD3-BFCC-7F2AEA9AE77AQ33890190-388F1AC3-4F03-4E1E-BB57-E9730CD0188DQ34019624-FC174AD6-5747-4ADF-8713-B0FFF8899CD8Q34129723-33AF489C-D675-4016-AEAB-95A2E0C959E0Q34361011-EA2BD98C-C59B-4C98-8DFC-F031CD5B84DFQ34388100-F4FE8C39-E29E-4083-9FD4-DED688CD3CE3Q34742783-0475457B-48B3-424D-B93A-62B1F043239CQ34974804-19224CFA-2DB3-487F-A1D6-442ABE30ADA8Q35028656-83C5FA7C-B063-4823-8422-C2101C6FF84EQ35074424-0F1B5130-1B82-482A-834F-D0572D07962AQ35745368-FD2A183F-1A4B-4C78-8D3E-AC2A919F5D72Q35786266-D05DF2CC-739D-4A7E-88C2-5AE7BA224D91Q35899528-43586B4A-2954-4D37-A710-2108C71C95F3Q36000112-D908C25A-C4E5-4A69-BC30-205CFABF11ABQ36107857-50772194-F4F0-4B29-A1B8-EB834C71F794Q36435617-51116E55-E61A-41B5-BC4A-CCDAD12D8429Q36443015-21441C3F-338D-4E49-A54F-71764223497FQ36603206-1BB53C7A-B350-4731-8AB0-4ED808E52C51Q37074551-A0AB7F79-B3F1-406E-817C-09E4D931B88AQ37349411-3DE7D6B4-23D0-48AE-B2A2-B71DB5393D6FQ37627388-B001D08D-B009-4AE9-AAD0-682427D32559Q38172127-81950C8A-8B7A-4EE0-BC5A-5E84D28274DCQ38264238-D2BB5309-9E05-4A1F-8CF5-9CD489E354C3Q38676419-0BC9DC6E-A67D-4D5C-A8A2-14408DB55291Q40736387-FE3A5862-EB74-465D-98E8-FD164F52CEE1Q43061550-3FA8A46D-9A76-47F6-B6BA-8E3F1A97C6FCQ44075521-80E919CE-2545-4130-ABA9-76415D0EF946Q44810284-8044629B-2CB8-4B8D-BC3F-D9BC7726A4D2
P2860
Sympathetic overactivity in hypertension. A moving target.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Sympathetic overactivity in hypertension. A moving target.
@en
type
label
Sympathetic overactivity in hypertension. A moving target.
@en
prefLabel
Sympathetic overactivity in hypertension. A moving target.
@en
P1476
Sympathetic overactivity in hypertension. A moving target.
@en
P2093
P304
P356
10.1016/0895-7061(96)00287-7
P577
1996-11-01T00:00:00Z